Moderna
MRNA
MRNA
1,134 hedge funds and large institutions have $93.4B invested in Moderna in 2021 Q3 according to their latest regulatory filings, with 321 funds opening new positions, 391 increasing their positions, 325 reducing their positions, and 74 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,134
Holders Change
+236
Holders Change %
+26.28%
% of All Funds
19.92%
Holding in Top 10
39
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+21.88%
% of All Funds
0.68%
New
321
Increased
391
Reduced
325
Closed
74
Calls
$8.43B
Puts
$9.72B
Net Calls
-$1.3B
Net Calls Change
-$577M
Top Buyers
| 1 |
BlackRock
New York
|
$10.3B |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
$10.5B |
| 3 |
State Street
Boston,
Massachusetts
|
$5.37B |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
$2.21B |
| 5 |
Northern Trust
Chicago,
Illinois
|
$1.33B |
Top Sellers
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
$16.2B |
| 2 |
FP
Flagship Pioneering
Cambridge,
Massachusetts
|
$6.77B |
| 3 |
TP
Theleme Partners
London,
United Kingdom
|
$1.52B |
| 4 |
Morgan Stanley
New York
|
$2.18B |
| 5 |
Renaissance Technologies
New York
|
$770M |
